AJP - Heart and Circulatory Physiology, Vol 266, Issue 2 422-H428, Copyright © 1994 by American Physiological Society

ARTICLES

Conversion of big ET-1 in the rat lung: role of phosphoramidon-sensitive endothelin-1-converting enzyme

K. Hisaki, Y. Matsumura, H. Maekawa, K. Fujita, M. Takaoka and S. Morimoto
Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Japan.

We examined conversion of Big endothelin-1 (ET-1) to mature ET-1 and pressor action during perfusion of the isolated perfused rat lung with Big ET-1. Big ET-1 caused a concentration-related increase in perfusion pressure and the pressor molar potency of the peptide was fivefold less than that of ET-1. Pressor responses to Big ET-1 were accompanied by an increase in immunoreactive-ET (IR-ET) levels in the perfusate and in the lung tissues. Pretreatment with phosphoramidon (10(-4) M), a metalloproteinase inhibitor, markedly suppressed the pressor action and increment in IR-ET in the tissues. Unexpectedly, the amount of IR-ET in the perfusate during perfusion of Big ET-1 was not influenced by phosphoramidon treatment. On the other hand, chymostatin, an inhibitor of chymotrypsin-like enzymes, effectively suppressed IR-ET levels in the perfusate; however, this enzyme inhibitor was without effect on the pressor action of Big ET-1 or on the increase in IR-ET levels in lung tissues. We tentatively conclude that the phosphoramidon-sensitive conversion of Big ET-T to ET-1 is linked to the pressor action of Big ET-1 in the isolated perfused rat lung. In addition, it seems likely that chymostatin-sensitive conversion of Big ET-1 to ET-1 does not play a major role in the conversion of the precursor to the mature form. We propose that IR-ET present in the tissues rather than that in the perfusate is a better indicator of the functional conversion of Big ET-1 in the rat lung.

This article has been cited by other articles:

				Y. Matsumura, T. Kuro, Y. Kobayashi, F. Konishi, M. Takaoka, J. L. Wessale, T. J. Opgenorth, C. E. Gariepy, and M. Yanagisawa Exaggerated Vascular and Renal Pathology in Endothelin-B Receptor-Deficient Rats With Deoxycorticosterone Acetate-Salt Hypertension Circulation, November 28, 2000; 102(22): 2765 - 2773. [Abstract] [Full Text] [PDF]

				M. Lauth, M.-M. Berger, M. Cattaruzza, and M. Hecker Elevated Perfusion Pressure Upregulates Endothelin-1 and Endothelin B Receptor Expression in the Rabbit Carotid Artery Hypertension, February 1, 2000; 35(2): 648 - 654. [Abstract] [Full Text] [PDF]

				M. Lauth, M.-M. Berger, M. Cattaruzza, and M. Hecker Pressure-Induced Upregulation of Preproendothelin-1 and Endothelin B Receptor Expression in Rabbit Jugular Vein In Situ : Implications for Vein Graft Failure? Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 96 - 103. [Abstract] [Full Text] [PDF]

				S. Naomi, T. Iwaoka, T. Disashi, J. Inoue, Y. Kanesaka, H. Tokunaga, and K. Tomita Endothelin-1 Inhibits Endothelin-Converting Enzyme-1 Expression in Cultured Rat Pulmonary Endothelial Cells Circulation, January 27, 1998; 97(3): 234 - 236. [Abstract] [Full Text] [PDF]

				K. Stangl, T. Dschietzig, M. Laule, K. Alexiou, K. D. Wernecke, and G. Baumann Pulmonary Big Endothelin Affects Coronary Tone and Leads to Enhanced, ETA-Mediated Coronary Constriction in Early Endothelial Dysfunction Circulation, November 4, 1997; 96(9): 3192 - 3200. [Abstract] [Full Text]

				P. Moreau, L. V. d'Uscio, S. Shaw, H. Takase, M. Barton, and T. F. Luscher Angiotensin II Increases Tissue Endothelin and Induces Vascular Hypertrophy : Reversal by ETA-Receptor Antagonist Circulation, September 2, 1997; 96(5): 1593 - 1597. [Abstract] [Full Text]